Moonen An, Boeckxstaens Guy
Department of Gastroenterology, Translational Research Center for Gastrointestinal Disorders (TARGID), University Hospital of Leuven, Catholic University of Leuven, Leuven, Belgium.
J Clin Gastroenterol. 2014 Jul;48(6):484-90. doi: 10.1097/MCG.0000000000000137.
Achalasia is the best characterized primary esophageal motility disorder of the esophagus and typically presents with absent peristalsis of the esophageal body and a failure of the lower esophageal sphincter to relax upon swallowing on manometry, associated with progressively severe dysphagia, regurgitation, aspiration, chest pain, and weight loss. The diagnosis is suggested by barium swallow and endoscopy, and confirmed by manometry. As there is no curative treatment for achalasia, treatment is confined to disruption of the lower esophageal sphincter to improve bolus passage. Treatment modalities available for this purpose include pneumatic dilation, laparoscopic Heller myotomy and since recently peroral endoscopic myotomy or POEM. In this review, we will discuss the current diagnosis, management, and treatment options of achalasia.
贲门失弛缓症是最典型的原发性食管动力障碍性疾病,其特征通常为食管体部蠕动消失,食管下段括约肌在吞咽时测压不能松弛,伴有进行性加重的吞咽困难、反流、误吸、胸痛和体重减轻。钡餐造影和内镜检查提示诊断,测压可确诊。由于贲门失弛缓症尚无治愈性治疗方法,治疗仅限于破坏食管下段括约肌以改善食团通过。为此可用的治疗方式包括气囊扩张、腹腔镜下Heller肌切开术,以及最近出现的经口内镜下肌切开术(POEM)。在本综述中,我们将讨论贲门失弛缓症的当前诊断、管理及治疗选择。